McDonnell Boehnen Hulbert & Berghoff LLP partner Andrew Williams, Ph.D. is quoted in an article entitled, “Novartis Exelon Patch Patent Battle: PTAB Can Disagree With District Court” that appears in the April 5, 2017 online edition of the Pharma Intelligence Pink Sheet. Federal Circuit rejects Novartis argument that Patent Trial and Appeal Board unlawfully concluded Exelon patents were unpatentable after a district court upheld them. View the article